Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
46,151
datasets available to search
ShareScore release 0.9.0
Dataset results
46,151 results for “Safety”
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer
ClinicalTrials.gov study NCT01958021. IPD Sharing: YES. Countries: 29. Publications: 12.
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
ClinicalTrials.gov study NCT03917472. IPD Sharing: YES. Countries: 5. Publications: 1.
Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients
ClinicalTrials.gov study NCT02445248. IPD Sharing: YES. Countries: 10. Publications: 12.
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
ClinicalTrials.gov study NCT01915303. IPD Sharing: YES. Countries: 16. Publications: 1.
A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
ClinicalTrials.gov study NCT01327053. IPD Sharing: YES. Countries: 12. Publications: 4.
Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
ClinicalTrials.gov study NCT03066609. IPD Sharing: UNDECIDED. Countries: 6. Publications: 1.
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
ClinicalTrials.gov study NCT02915302. IPD Sharing: YES. Countries: 2. Publications: 1.
Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia
ClinicalTrials.gov study NCT04382053. IPD Sharing: YES. Countries: 12. Publications: 1.
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation
ClinicalTrials.gov study NCT04456673. IPD Sharing: YES. Countries: 29. Publications: 2.
A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03738397. IPD Sharing: YES. Countries: 23. Publications: 3.
Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults
ClinicalTrials.gov study NCT04498832. IPD Sharing: YES. Countries: 1. Publications: 1.
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
ClinicalTrials.gov study NCT01197300. IPD Sharing: YES. Countries: 6. Publications: 5.
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
ClinicalTrials.gov study NCT02159053. IPD Sharing: UNDECIDED. Countries: 19. Publications: 6.
The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04389671. IPD Sharing: NO. Countries: 2. Publications: 2.
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD
ClinicalTrials.gov study NCT03846193. IPD Sharing: YES. Countries: 2. Publications: 1.
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
ClinicalTrials.gov study NCT03610516. IPD Sharing: YES. Countries: 10. Publications: 1.
Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
ClinicalTrials.gov study NCT02034110. IPD Sharing: YES. Countries: 14. Publications: 8.
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPR
ClinicalTrials.gov study NCT02476006. IPD Sharing: YES. Countries: 16. Publications: 1.
A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT04486716. IPD Sharing: YES. Countries: 2. Publications: 1.
Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery
ClinicalTrials.gov study NCT02152761. IPD Sharing: UNDECIDED. Countries: 19. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.